To address whether CD133+ and CD133− cells differed in their ability to form tumors in vivo, we inoculated CD133+ or CD133− cells derived from C6 glioma cells (1 × 104) subcutaneously into the nude mice. The gene discussed is PROM1; the disease is glioma.